Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Healthcare costs in the U.S. continue to rise, making it difficult for millions of people to afford essential medical ...

Global healthcare leader Abbott has developed Ensure Gold, a science-based nutrition solution available in both powder and ...

The 501(c)3 non-profit Tidepool, which seeks to empower the next generation of innovations in diabetes management ... device similar to Abbott’s FreeStyle Libre 3 device. Apple has the FDA ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...